MyFinsight
Home
About
Contact
qncx: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, QNCX has $109,899K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Buy me a coffee
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
109,899
117,210
Total stockholders equity
1,059
11,736
Total liabilities and stockholders equity
109,899
117,210
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Subscribe for Financial Insights
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Prepaid expenses and
other current assets
$2,914K
Short-term investments
$19,836K
Cash and cash
equivalents
$6,452K
Other assets
$11,874K
Intangible assets
$67,726K
Operating lease
right-of-use assets
$481K
Property and equipment,
net
$616K
Total current assets
$29,202K
Total assets
$109,899K
Total liabilities and
stockholders equity
$109,899K
Total stockholders
equity
$1,059K
Total liabilities
$108,840K
Accumulated deficit
-$420,993K
Accumulated other
comprehensive income (loss)
$6,293K
Other long-term
liabilities
$778K
Warrant liabilities
$14,853K
Deferred tax liabilities
$5,593K
Long-term contingent
consideration
$61,213K
Long-term operating lease
liabilities
$359K
Total current
liabilities
$26,044K
Additional paid in capital
$415,705K
Common stock, 0.001 par
value, 250,000,000...
$54K
Current portion of debt
$17,520K
Accrued expenses and
other current...
$5,121K
Accounts payable
$3,403K
Subscribe for Financial Insights
Quince Therapeutics, Inc. (QNCX)
Quince Therapeutics, Inc. (QNCX)